Clinical Trial Update: Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities [Phase 4]

View source ↗

Summary

Phase IV trial comparing MICARDIS 80 mg to amlodipine 10 mg assessing biological PPAR gamma activities in hypertension and metabolic syndrome X.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Metabolic Syndrome

Drugs mentioned

• Amlodipine (amlodipine)
• Micardis (telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension, Metabolic Syndrome X | Phase 4 | Status: COMPLETED